Eli Lilly and Company was founded in 1876 by Colonel Eli Lilly to produce high quality pharmaceutical products based on science rather than advertisements. Some of Lilly's major products included Prozac, Zyprexa, Humulin insulin, and Ceclor antibiotic. In the 1980s, Lilly adopted genetic engineering and rational drug design, and in the late 1980s began using combinatorial chemistry to accelerate drug development. In 1994, Lilly acquired Sphinx Pharmaceuticals to gain expertise in combinatorial chemistry and high-throughput screening. Lilly used these methods in projects targeting central nervous system disorders like depression and migraine.